Print this page

Estimated reading time: 0 minutes, 31 seconds

Russian Supreme Court Denies Gilead’s Patent Lawsuit Over Anti-COVID Drug  

Russia’s Supreme Court rejected a lawsuit filed by Gilead Sciences, a U.S. biotech firm, after the Russian government allowed another company to produce Gilead’s anti-COVID-19 drug named remdesivir. So reports Reuters.

covid 4948866 640smallPharmasyntez, the Russian company, has been given a “compulsory license” to make the drug for one year without the permission of Gilead. “The government said in a decree at the time that the move was in the interests of Russia’s own security,” according to the article. “According to the decree, Russia had to pay compensation to the drug’s patent-holder. The amount was not specified.”

Read the full article from Reuters.

Read 1778 times
Rate this item
(0 votes)